Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK.
Miller PN, et al. Among authors: hirose r, hirose k.
Ann Surg Oncol. 2024 Sep;31(9):6147-6156. doi: 10.1245/s10434-024-15579-0. Epub 2024 Jun 15.
Ann Surg Oncol. 2024.
PMID: 38879670
Free PMC article.